Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCENTAGE-B

68.450
+1.2001.78%
Volume:1.07M
Turnover:73.18M
Market Cap:25.53B
PE:-46.57
High:69.100
Open:66.450
Low:66.400
Close:67.250
52wk High:95.350
52wk Low:31.350
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:1.31
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.470
ROE:-159.65%
ROA:-22.77%
PB:35.01
PE(LYR):-46.57
PS:59.69

Loading ...

Ascentage Pharma Announces Global Registrational Phase Iii Study of Lisaftoclax for First-Line Treatment of Patients With Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and Ema

THOMSON REUTERS
·
Aug 18

Ascentage Pharma Group International - FDA and Ema Clear Phase Iii Study of Lisaftoclax for Hr-Mds

THOMSON REUTERS
·
Aug 18

Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

THOMSON REUTERS
·
Aug 07

Ascentage Pharma Group International : JP Morgan Raises Target Price to $46 From $27

THOMSON REUTERS
·
Aug 06

HK Movers | Biotech Stocks Extend Rally. Junshi Bio up over 24%; Genor up 23%; Ascletis up 15%; Ascentage up 13%; Dualitybio up 12%

Tiger Newspress
·
Aug 05

Ascentage Pharma to Participate in Evercore China Biotech Summit in Shanghai

Reuters
·
Aug 01

Ascentage Pharma Raises HK$1.5 Billion from Share Sale; Shares Jump 3%

MT Newswires Live
·
Jul 28

Ascentage Pharma Announces Increase in Share Capital: 22 Million New Shares Issued at HK$68.6 Each

Reuters
·
Jul 25

Ascentage Pharma Group International Completes HKD1.492 Billion Offshore Private Placement to Boost Global Operations

Reuters
·
Jul 17

Hong Kong Stock Movement | Ascentage Pharma (06855.HK) Surges Over 4% in Morning Session After Raising HK$1.5B Via Placement to Accelerate Commercialization and Drug Pipeline Development

Deep News
·
Jul 16

Ascentage Pharma (06855) Gains Over 4% Pre-Market on HK$1.49B Share Placement to Fuel Commercialization and R&D

Stock News
·
Jul 16

Hong Kong Stocks Continue Rally as China's GDP Growth Slows Less Than Expected in Q2; Grand Ming Group Soars on Waivers of Loan Covenants

MT Newswires Live
·
Jul 15

Ascentage Pharma Seeking HK$1.5 Billion via Stock Sale; Shares Fall 6% in Pre-market Trade

MT Newswires Live
·
Jul 15

Ascentage Pharma Group International Announces Placing of Existing Shares and Top-Up Subscription of New Shares

Reuters
·
Jul 15

BRIEF-Ascentage Pharma Group International Prices 22 Mln Shares At HKD 68.60 Each

Reuters
·
Jul 14

Ascentage Pharma Gets China Nod for Lymphocytic Leukemia, Lymphoma Drug

MT Newswires Live
·
Jul 10

Ascentage Pharma's Novel Bcl-2 Inhibitor Lisaftoclax Receives Approval from China's NMPA for Treatment of CLL/SLL Patients

Reuters
·
Jul 10

Ascentage Pharma Group International Announces Key Management Appointments: Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development and Finance

Reuters
·
Jul 08

Ascentage Pharma Announces New Compensation Plan Under 2021 and 2022 RSU Schemes to Reward and Retain Key Talent

Reuters
·
Jun 27

Ascentage Pharma Unveils Promising Results from Olverembatinib and APG-5918 Clinical Studies at 2025 EHA Congress

Reuters
·
Jun 16